Ion Beam Applications SA (EBR:IBAB)

Market Cap	326.83M
Revenue (ttm)	465.75M
Net Income (ttm)	7.85M
Shares Out	29.18M
EPS (ttm)	0.27
PE Ratio	41.60
Forward PE	13.02
Dividend	0.17 (1.52%)
Ex-Dividend Date	Jun 19, 2024

Volume	15,939
Average Volume	37,967
Open	11.20
Previous Close	11.28
Day's Range	11.16 - 11.46
52-Week Range	10.70 - 15.14
Beta	0.91
RSI	32.58
Earnings Date	Mar 20, 2025

About Ion Beam Applications

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclot...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,145
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB